Understanding, predicting and achieving liver transplant tolerance: from bench to bedside

AW Thomson, J Vionnet… - Nature Reviews …, 2020 - nature.com
In the past 40 years, liver transplantation has evolved from a high-risk procedure to one that
offers high success rates for reversal of liver dysfunction and excellent patient and graft …

[HTML][HTML] Natural killer cells and liver transplantation: orchestrators of rejection or tolerance?

C Harmon, A Sanchez-Fueyo, C O'farrelly… - American Journal of …, 2016 - Elsevier
Natural killer (NK) cells are highly heterogeneous innate lymphocytes with a diverse
repertoire of phenotypes and functions. Their role in organ transplantation has been poorly …

[HTML][HTML] Human intestinal allografts contain functional hematopoietic stem and progenitor cells that are maintained by a circulating pool

J Fu, J Zuber, M Martinez, B Shonts, A Obradovic… - Cell Stem Cell, 2019 - cell.com
Human intestinal transplantation often results in long-term mixed chimerism of donor and
recipient blood in transplant patients. We followed the phenotypes of chimeric peripheral …

[HTML][HTML] Hematopoietic stem and progenitor cells outside the bone marrow: where, when, and why

N Mende, E Laurenti - Experimental hematology, 2021 - Elsevier
Highlights•Rare HSPCs are found in blood and tissues such as spleen, liver, and
lung.•Extramedullary HSPCs contribute to blood formation under stress conditions.•The …

No evidence for circulating mesenchymal stem cells in patients with organ injury

MJ Hoogduijn, MMA Verstegen, AU Engela… - Stem cells and …, 2014 - liebertpub.com
Mesenchymal stem cells (MSC) are present in the bone marrow, from where they are
thought to migrate through the blood stream to the sites of injury. However, virtually all …

[HTML][HTML] Macrochimerism in intestinal transplantation: association with lower rejection rates and multivisceral transplants, without GVHD

J Zuber, S Rosen, B Shonts, B Sprangers… - American Journal of …, 2015 - Elsevier
Blood chimerism has been reported sporadically among visceral transplant recipients,
mostly in association with graft-vs-host disease (GVHD). We hypothesized that a higher …

Successful treatment of pediatric refractory Burkitt lymphoma PTLD after liver transplantation using anti-CD19 chimeric antigen receptor T-cell therapy

T Wang, M Feng, C Luo, X Wan, C Pan… - Cell …, 2021 - journals.sagepub.com
In the immunocompromised setting, recipients of solid-organ or hematopoietic stem-cell
transplants carry an increased risk of post-transplant lymphoproliferative disorder (PTLD) …

Single-cell analysis reveals the origins and intrahepatic development of liver-resident IFN-γ-producing γδ T cells

Y Hu, K Fang, Y Wang, N Lu, H Sun… - Cellular & Molecular …, 2021 - nature.com
Abstract γδ T cells are heterogeneous lymphocytes located in various tissues. However, a
systematic and comprehensive understanding of the origins of γδ T cell heterogeneity and …

Transplant tolerance induction: insights from the liver

H Dai, Y Zheng, AW Thomson, NM Rogers - Frontiers in immunology, 2020 - frontiersin.org
A comparison of pre-clinical transplant models and of solid organs transplanted in routine
clinical practice demonstrates that the liver is most amenable to the development of …

[HTML][HTML] Immunotolerance in liver transplantation: a primer for the clinician

J Pérez-Escobar, JV Jimenez, EF Rodríguez-Aguilar… - Annals of …, 2023 - Elsevier
The use of immunosuppressive medications for solid organ transplantation is associated
with cardiovascular, metabolic, and oncologic complications. On the other hand, the …